Gotham Asset Management’s Meridian Bioscience Inc VIVO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q1 | – | Sell |
-10,058
| Closed | -$334K | – | 1422 |
|
|
2022
Q4 | $334K | Sell |
10,058
-11,850
| -54% | -$382K | 0.01% | 1009 |
|
|
2022
Q3 | $691K | Buy |
+21,908
| New | +$709K | 0.02% | 765 |
|
|
2021
Q3 | – | Sell |
-38,180
| Closed | -$847K | – | 1150 |
|
|
2021
Q2 | $847K | Buy |
38,180
+13,843
| +57% | +$294K | 0.04% | 526 |
|
|
2021
Q1 | $639K | Sell |
24,337
-8,247
| -25% | -$196K | 0.03% | 613 |
|
|
2020
Q4 | $609K | Buy |
32,584
+20,101
| +161% | +$375K | 0.02% | 667 |
|
|
2020
Q3 | $212K | Buy |
12,483
+746
| +6% | +$14.5K | 0.01% | 926 |
|
|
2020
Q2 | $273K | Sell |
11,737
-2,096
| -15% | -$30.4K | 0.01% | 878 |
|
|
2020
Q1 | $116K | Buy |
+13,833
| New | +$116K | ﹤0.01% | 988 |
|
|
2019
Q4 | – | Sell |
-20,438
| Closed | -$194K | – | 1250 |
|
|
2019
Q3 | $194K | Sell |
20,438
-11,915
| -37% | -$126K | ﹤0.01% | 1021 |
|
|
2019
Q2 | $384K | Sell |
32,353
-910
| -3% | -$11K | 0.01% | 875 |
|
|
2019
Q1 | $586K | Buy |
33,263
+15,515
| +87% | +$258K | 0.01% | 811 |
|
|
2018
Q4 | $308K | Sell |
17,748
-6,538
| -27% | -$112K | ﹤0.01% | 857 |
|
|
2018
Q3 | $362K | Sell |
24,286
-2,107
| -8% | -$32.7K | 0.01% | 802 |
|
|
2018
Q2 | $420K | Sell |
26,393
-14,941
| -36% | -$223K | 0.01% | 725 |
|
|
2018
Q1 | $587K | Sell |
41,334
-118,582
| -74% | -$1.75M | 0.01% | 693 |
|
|
2017
Q4 | $2.24M | Sell |
159,916
-36,298
| -18% | -$531K | 0.03% | 480 |
|
|
2017
Q3 | $2.81M | Sell |
196,214
-18,013
| -8% | -$257K | 0.04% | 464 |
|
|
2017
Q2 | $3.37M | Sell |
214,227
-20,054
| -9% | -$289K | 0.05% | 435 |
|
|
2017
Q1 | $3.23M | Buy |
234,281
+23,000
| +11% | +$322K | 0.04% | 473 |
|
|
2016
Q4 | $3.74M | Sell |
211,281
-35,617
| -14% | -$626K | 0.05% | 426 |
|
|
2016
Q3 | $4.76M | Sell |
246,898
-17,352
| -7% | -$340K | 0.06% | 360 |
|
|
2016
Q2 | $5.15M | Buy |
264,250
+93,073
| +54% | +$1.83M | 0.06% | 383 |
|
|
2016
Q1 | $3.53M | Buy |
171,177
+84,701
| +98% | +$1.67M | 0.04% | 489 |
|
|
2015
Q4 | $1.77M | Sell |
86,476
-95,592
| -53% | -$1.83M | 0.02% | 534 |
|
|
2015
Q3 | $3.11M | Sell |
182,068
-89,247
| -33% | -$1.63M | 0.03% | 486 |
|
|
2015
Q2 | $5.06M | Sell |
271,315
-11,747
| -4% | -$218K | 0.04% | 448 |
|
|
2015
Q1 | $5.4M | Buy |
283,062
+223,625
| +376% | +$4.14M | 0.04% | 421 |
|
|
2014
Q4 | $978K | Buy |
59,437
+5,810
| +11% | +$99.7K | 0.01% | 629 |
|
|
2014
Q3 | $949K | Sell |
53,627
-8,014
| -13% | -$157K | 0.01% | 635 |
|
|
2014
Q2 | $1.27M | Sell |
61,641
-319
| -0.5% | -$6.55K | 0.02% | 605 |
|
|
2014
Q1 | $1.35M | Sell |
61,960
-52,847
| -46% | -$1.21M | 0.02% | 595 |
|
|
2013
Q4 | $3.05M | Sell |
114,807
-40,499
| -26% | -$995K | 0.07% | 391 |
|
|
2013
Q3 | $3.67M | Buy |
155,306
+71,393
| +85% | +$1.67M | 0.12% | 271 |
|
|
2013
Q2 | $1.8M | Buy |
+83,913
| New | +$1.81M | 0.08% | 386 |
|
Other funds holding VIVO
Gotham Asset Management's VIVO Position: Q1 2023 in Review
Gotham Asset Management sold out of Meridian Bioscience Inc (VIVO) in Q1 2023, closing a stake of 10,058 shares — an estimated $334K sold.
Gotham Asset Management first reported a position in VIVO in Q2 2013 and held it in 34 quarters. The position peaked at $5.4M in Q1 2015. 2 funds tracked by Wall St. Rank hold VIVO as of Q1 2023.
- Gotham Asset Management reported no remaining Meridian Bioscience Inc position as of Q1 2023 after selling out during the quarter.
- Gotham Asset Management sold 10,058 Meridian Bioscience Inc shares in Q1 2023, an estimated $334K.
- Gotham Asset Management first reported a position in Meridian Bioscience Inc in Q2 2013 and held it in 34 quarters.
- Gotham Asset Management's Meridian Bioscience Inc position peaked at $5.4M in Q1 2015.
- 2 funds tracked by Wall St. Rank held Meridian Bioscience Inc as of Q1 2023.
Based on Gotham Asset Management's 13F filing for Q1 2023, filed 15 May 2023.